Body mass index, body composition, immunotherapy, T cell exclusion, tumor immune microenvironment
TMAO, IS, PCS, partial nephrectomy, cardiovascular events.
Immunotherapy, tyrosine kinase inhibitor, safety, efficacy, non clear cell renal cell carcinoma
Metastasis-directed therapy, Oligometastatic, Renal cell carcinoma, Stereotactic body radiotherapy, Sunitinib